Cargando…
Could paraprobiotics be a safer alternative to probiotics for managing cancer chemotherapy-induced gastrointestinal toxicities?
Clinical oncology has shown outstanding progress improving patient survival due to the incorporation of new drugs. However, treatment success may be reduced by the emergency of dose-limiting side effects, such as intestinal mucositis and diarrhea. Mucositis and diarrhea management is symptomatic, an...
Autores principales: | Nobre, L.M.S., Fernandes, C., Florêncio, K.G.D., Alencar, N.M.N., Wong, D.V.T., Lima-Júnior, R.C.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843735/ https://www.ncbi.nlm.nih.gov/pubmed/36651453 http://dx.doi.org/10.1590/1414-431X2022e12522 |
Ejemplares similares
-
Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
por: Batista, Viviane Lima, et al.
Publicado: (2020) -
Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD
por: Martyniak, Adrian, et al.
Publicado: (2021) -
Potential Health-Promoting Benefits of Paraprobiotics, Inactivated Probiotic Cells
por: Akter, Shahina, et al.
Publicado: (2020) -
Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune Systems
por: Kanauchi, Osamu, et al.
Publicado: (2018) -
Paraprobiotics and Postbiotics of Probiotic Lactobacilli, Their Positive Effects on the Host and Action Mechanisms: A Review
por: Teame, Tsegay, et al.
Publicado: (2020)